MXPA05007876A - Camsilato de amlodipino amorfo, estable, proceso para preparar el mismo y composicion para la administracion oral del mismo. - Google Patents
Camsilato de amlodipino amorfo, estable, proceso para preparar el mismo y composicion para la administracion oral del mismo.Info
- Publication number
- MXPA05007876A MXPA05007876A MXPA05007876A MXPA05007876A MXPA05007876A MX PA05007876 A MXPA05007876 A MX PA05007876A MX PA05007876 A MXPA05007876 A MX PA05007876A MX PA05007876 A MXPA05007876 A MX PA05007876A MX PA05007876 A MXPA05007876 A MX PA05007876A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- oral administration
- preparing same
- stable amorphous
- amlodipine camsylate
- Prior art date
Links
- UXKMFEPPKJZDAR-STOWLHSFSA-N [(1r,4s)-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid;3-o-ethyl 5-o-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl UXKMFEPPKJZDAR-STOWLHSFSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
Classifications
-
- E—FIXED CONSTRUCTIONS
- E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
- E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
- E06B5/00—Doors, windows, or like closures for special purposes; Border constructions therefor
- E06B5/10—Doors, windows, or like closures for special purposes; Border constructions therefor for protection against air-raid or other war-like action; for other protective purposes
- E06B5/16—Fireproof doors or similar closures; Adaptations of fixed constructions therefor
- E06B5/161—Profile members therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2255/00—Coating on the layer surface
- B32B2255/08—Coating on the layer surface on wood layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/30—Properties of the layers or laminate having particular thermal properties
- B32B2307/306—Resistant to heat
- B32B2307/3065—Flame resistant or retardant, fire resistant or retardant
-
- E—FIXED CONSTRUCTIONS
- E05—LOCKS; KEYS; WINDOW OR DOOR FITTINGS; SAFES
- E05Y—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES E05D AND E05F, RELATING TO CONSTRUCTION ELEMENTS, ELECTRIC CONTROL, POWER SUPPLY, POWER SIGNAL OR TRANSMISSION, USER INTERFACES, MOUNTING OR COUPLING, DETAILS, ACCESSORIES, AUXILIARY OPERATIONS NOT OTHERWISE PROVIDED FOR, APPLICATION THEREOF
- E05Y2900/00—Application of doors, windows, wings or fittings thereof
- E05Y2900/10—Application of doors, windows, wings or fittings thereof for buildings or parts thereof
- E05Y2900/13—Type of wing
- E05Y2900/132—Doors
- E05Y2900/134—Fire doors
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Esta invencion se refiere a una forma amorfa, estable de camsilato de amlodipino que tiene una solubilidad alta, que puede usarse de manera eficiente en el tratamiento de enfermedades cardiovasculares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030005227 | 2003-01-27 | ||
PCT/KR2004/000136 WO2004067512A1 (en) | 2003-01-27 | 2004-01-27 | Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05007876A true MXPA05007876A (es) | 2005-09-21 |
Family
ID=36147033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05007876A MXPA05007876A (es) | 2003-01-27 | 2004-01-27 | Camsilato de amlodipino amorfo, estable, proceso para preparar el mismo y composicion para la administracion oral del mismo. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060128763A1 (es) |
EP (1) | EP1587792B1 (es) |
JP (1) | JP2007528349A (es) |
KR (1) | KR100558505B1 (es) |
CN (1) | CN1777586A (es) |
BR (1) | BRPI0407038A (es) |
ES (1) | ES2500292T3 (es) |
MX (1) | MXPA05007876A (es) |
WO (1) | WO2004067512A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100742432B1 (ko) * | 2005-12-27 | 2007-07-24 | 한미약품 주식회사 | 암로디핀 캠실레이트 및 심바스타틴을 포함하는 복합제제,및 이의 제조방법 |
KR100913791B1 (ko) * | 2006-07-21 | 2009-08-26 | 한미약품 주식회사 | (s)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물 |
KR100821688B1 (ko) | 2006-08-10 | 2008-04-11 | (주)유케이케미팜 | 암로디핀 라셈화물의 입체이성질체의 분리방법과 그의친수성 약물 및 그의 제조방법 |
KR101247583B1 (ko) * | 2006-12-08 | 2013-03-26 | 한미사이언스 주식회사 | 암로디핀 또는 이의 약제학적 허용가능한 염, 및 로자탄또는 이의 약제학적 허용가능한 염을 함유하는 약제학적조성물 |
MX349221B (es) | 2009-01-23 | 2017-07-19 | Hanmi Science Co Ltd * | Composicion farmaceutica solida que comprende amlodipina y losartan y procesos para producir la misma. |
EP3039011A1 (en) * | 2013-08-29 | 2016-07-06 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
JP6339364B2 (ja) * | 2013-12-27 | 2018-06-06 | カズマパートナーズ株式会社 | 無定形ブリモニジン酒石酸塩及びその製造方法 |
CN116332832A (zh) * | 2023-03-29 | 2023-06-27 | 安徽美致诚药业有限公司 | 一种马来酸左旋氨氯地平无定型晶型及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
KR950007228B1 (ko) | 1987-08-05 | 1995-07-07 | 화이자 인코포레이티드 | 암로디핀의 베실레이트염 |
KR100363566B1 (ko) * | 1998-11-20 | 2003-08-19 | 국제약품공업주식회사 | 무정형 세푸록심 악세틸의 제조방법 |
EP1309557B9 (en) * | 2000-12-29 | 2006-11-15 | Pfizer Limited | Amlodipine hemimaleate |
CZ20031779A3 (cs) * | 2000-12-29 | 2004-10-13 | Bioorganicsáb@V | Způsob přípravy amlodipinuŹ jeho derivátů a jejich prekurzorů |
WO2002053538A1 (en) * | 2000-12-29 | 2002-07-11 | Pfizer Limited | Amlodipine fumarate |
DE10112764A1 (de) * | 2001-03-16 | 2002-09-19 | Mann & Hummel Filter | Radialverdichter |
KR100452491B1 (ko) * | 2001-03-29 | 2004-10-12 | 한미약품 주식회사 | 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법 |
AR037565A1 (es) * | 2001-11-21 | 2004-11-17 | Synthon Bv | Formas de sales de amlodipina y procedimientos para prepararlas. |
-
2004
- 2004-01-27 US US10/543,358 patent/US20060128763A1/en not_active Abandoned
- 2004-01-27 WO PCT/KR2004/000136 patent/WO2004067512A1/en active Search and Examination
- 2004-01-27 KR KR1020040005089A patent/KR100558505B1/ko active IP Right Grant
- 2004-01-27 MX MXPA05007876A patent/MXPA05007876A/es active IP Right Grant
- 2004-01-27 CN CNA200480002970XA patent/CN1777586A/zh active Pending
- 2004-01-27 ES ES04705547.0T patent/ES2500292T3/es not_active Expired - Lifetime
- 2004-01-27 EP EP04705547.0A patent/EP1587792B1/en not_active Expired - Lifetime
- 2004-01-27 JP JP2006502689A patent/JP2007528349A/ja active Pending
- 2004-01-27 BR BR0407038-0A patent/BRPI0407038A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0407038A (pt) | 2006-01-17 |
WO2004067512A1 (en) | 2004-08-12 |
US20060128763A1 (en) | 2006-06-15 |
EP1587792A4 (en) | 2011-03-09 |
EP1587792A1 (en) | 2005-10-26 |
ES2500292T3 (es) | 2014-09-30 |
CN1777586A (zh) | 2006-05-24 |
KR20040068877A (ko) | 2004-08-02 |
JP2007528349A (ja) | 2007-10-11 |
KR100558505B1 (ko) | 2006-03-07 |
EP1587792B1 (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0204235A3 (en) | Substituted glutarimides and use thereof il-12 production inhibitors, process for their preparation and pharmaceutical compositions containing them | |
IL159724A0 (en) | A nitrogen oxide generating composition for treatment of nail infections | |
HUP0302487A3 (en) | New mandelic acid derivatives and their use as throbin inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0201646A3 (en) | Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them | |
MXPA02012795A (es) | Carvedilol. | |
HUP0301742A3 (en) | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use | |
PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
HUP0301651A2 (en) | Indolylmaleimide derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
MXPA05008368A (es) | 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana. | |
IL140419A0 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
HK1097774A1 (en) | Stable pharmaceutical composition comprising linezolid from iv | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
MX2007002470A (es) | Fenilaminotiazoles sustituidos y su uso. | |
WO2004113297A3 (en) | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
MY141743A (en) | 3h-quinazolin-4-one derivatives | |
MXPA05007876A (es) | Camsilato de amlodipino amorfo, estable, proceso para preparar el mismo y composicion para la administracion oral del mismo. | |
MXPA05013758A (es) | Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas. | |
WO2002098850A3 (en) | Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors | |
IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
IL161039A0 (en) | Mupirocin compositions for topical use, and improved process of making same and methods of using same | |
MXPA03001356A (es) | Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status | ||
GD | Licence granted |